ListarInvestigación y Desarrollo por tema "Alzheimer's disease"
Mostrando ítems 21-33 de 33
-
Review
-
Article
Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer's disease (2020)
(Frontiers Media S.A., 2017) -
Article
Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease (2020)
(Bentham Science Publishers B.V., 2017) -
Article
-
Review
Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease (2020)
(Blackwell Publishing Ltd, 2020) -
Conference Paper
-
Article
-
Review
Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease (2020)
(Elsevier B.V., 2020) -
Article
Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons (2020)
(Academic Press Inc., 2014) -
Article
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders (2024)
(Elsevier Masson s.r.l., 2022)Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered a direct negative regulator of several receptor and receptor-associated tyrosine kinases. This widely localized enzyme has been ... -
Article
-
Article
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders (2024)
(BioMed Central Ltd, 2022)Neurological disorders (NDs) are characterized by progressive neuronal dysfunction leading to synaptic failure, cognitive impairment, and motor injury. Among these diseases, Alzheimer's disease (AD), Parkinson's disease ... -
Article
Trehalose against Alzheimer's Disease: Insights into a Potential Therapy (2020)
(John Wiley and Sons Inc., 2020)